MME and prostate cancer: Further studies are warranted to establish the radiotheranostic value of the [111In]In-AU-SAR-M1/[177Lu]Lu-AU-SAR-M1 pair, alone or during NEP-inhibition, in the management of prostate cancer or other GRPR-expressing malignancies.